| Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade J Hsu, JJ Hodgins, M Marathe, CJ Nicolai, MC Bourgeois-Daigneault, ... The Journal of clinical investigation 128 (10), 4654-4668, 2018 | 610 | 2018 |
| Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy MC Bourgeois-Daigneault, DG Roy, AS Aitken, N El Sayes, NT Martin, ... Science translational medicine 10 (422), eaao1641, 2018 | 276 | 2018 |
| Methionine metabolism shapes T helper cell responses through regulation of epigenetic reprogramming DG Roy, J Chen, V Mamane, EH Ma, BM Muhire, RD Sheldon, ... Cell metabolism 31 (2), 250-266. e9, 2020 | 191 | 2020 |
| Interleukin‐10‐induced MARCH1 mediates intracellular sequestration of MHC class II in monocytes J Thibodeau, MC Bourgeois‐Daigneault, G Huppé, J Tremblay, A Aumont, ... European journal of immunology 38 (5), 1225-1230, 2008 | 183 | 2008 |
| Targeting the MHC Class II antigen presentation pathway in cancer immunotherapy J Thibodeau, MC Bourgeois-Daigneault, R Lapointe Oncoimmunology 1 (6), 908-916, 2012 | 160 | 2012 |
| VEGF-mediated induction of PRD1-BF1/Blimp1 expression sensitizes tumor vasculature to oncolytic virus infection R Arulanandam, C Batenchuk, FA Angarita, K Ottolino-Perry, ... Cancer Cell 28 (2), 210-224, 2015 | 98 | 2015 |
| Sorting of MHC class II molecules into exosomes through a ubiquitin‐independent pathway MÉ Gauvreau, MH Côté, MC Bourgeois‐Daigneault, LD Rivard, F Xiu, ... Traffic 10 (10), 1518-1527, 2009 | 83 | 2009 |
| Oncolytic vesicular stomatitis virus expressing interferon-σ has enhanced therapeutic activity MC Bourgeois-Daigneault, DG Roy, T Falls, K Twumasi-Boateng, ... Molecular Therapy-Oncolytics 3, 2016 | 80 | 2016 |
| Combination of Paclitaxel and MG1 oncolytic virus as a successful strategy for breast cancer treatment MC Bourgeois-Daigneault, LE St-Germain, DG Roy, A Pelin, AS Aitken, ... Breast Cancer Research 18 (1), 1-10, 2016 | 79 | 2016 |
| MARCH1 regulates insulin sensitivity by controlling cell surface insulin receptor levels A Nagarajan, MC Petersen, AR Nasiri, G Butrico, A Fung, HB Ruan, ... Nature communications 7 (1), 12639, 2016 | 74 | 2016 |
| Oncolytic measles virus encoding interleukin-12 mediates potent antitumor effects through T cell activation R Veinalde, C Grossardt, L Hartmann, MC Bourgeois-Daigneault, JC Bell, ... Oncoimmunology 6 (4), e1285992, 2017 | 73 | 2017 |
| Amplification of oncolytic vaccinia virus widespread tumor cell killing by sunitinib through multiple mechanisms M Kim, M Nitschké, B Sennino, P Murer, BJ Schriver, A Bell, ... Cancer research 78 (4), 922-937, 2018 | 60 | 2018 |
| Autoregulation of MARCH1 expression by dimerization and autoubiquitination MC Bourgeois-Daigneault, J Thibodeau The Journal of Immunology 188 (10), 4959-4970, 2012 | 49 | 2012 |
| Taking a stab at cancer; oncolytic virus-mediated anti-cancer vaccination strategies AS Aitken, DG Roy, MC Bourgeois-Daigneault Biomedicines 5 (1), 3, 2017 | 42 | 2017 |
| Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination DG Roy, K Geoffroy, M Marguerie, ST Khan, NT Martin, J Kmiecik, ... Nature Communications 12 (1), 2626, 2021 | 33 | 2021 |
| Pre-surgical neoadjuvant oncolytic virotherapy confers protection against rechallenge in a murine model of breast cancer NT Martin, DG Roy, ST Workenhe, DJM Van Den Wollenberg, ... Scientific reports 9 (1), 1865, 2019 | 31 | 2019 |
| MARCH1 E3 ubiquitin ligase dampens the innate inflammatory response by modulating monocyte functions in mice T Galbas, M Raymond, A Sabourin, MC Bourgeois-Daigneault, ... The Journal of Immunology 198 (2), 852-861, 2017 | 31 | 2017 |
| In silico trials predict that combination strategies for enhancing vesicular stomatitis oncolytic virus are determined by tumor aggressivity AL Jenner, T Cassidy, K Belaid, MC Bourgeois-Daigneault, M Craig Journal for immunotherapy of cancer 9 (2), 2021 | 24 | 2021 |
| The pros and cons of interferons for oncolytic virotherapy K Geoffroy, MC Bourgeois-Daigneault Cytokine & Growth Factor Reviews 56, 49-58, 2020 | 24 | 2020 |
| Cutting edge: HLA-DO impairs the incorporation of HLA-DM into exosomes F Xiu, MH Côté, MC Bourgeois-Daigneault, A Brunet, MÉ Gauvreau, ... The Journal of Immunology 187 (4), 1547-1551, 2011 | 21 | 2011 |
